Cargando…
Characteristics of State Legislation Addressing Prescription Drug Price Increases in the United States, 2020
Autores principales: | Shahriar, Arman A., Vazquez Benitez, Gabriela, Pawloski, Pamala A., Dehmer, Steven P., Alpern, Jonathan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086023/ https://www.ncbi.nlm.nih.gov/pubmed/34047918 http://dx.doi.org/10.1007/s11606-021-06838-x |
Ejemplares similares
-
Characteristics and Price Increases Among Sole-Source, Off-Patent Drugs in the United States, 2008 to 2018
por: Alpern, Jonathan D., et al.
Publicado: (2020) -
Antiparasitic Drugs in the United States—Two Roads to High Prices
por: Shahriar, Arman A., et al.
Publicado: (2020) -
Surveillance practices and air-sampling strategies to address healthcare-associated invasive mold infections in Society for Healthcare Epidemiology of America (SHEA) Research Network hospitals—United States, 2020
por: Gold, Jeremy A. W., et al.
Publicado: (2022) -
Characteristics of Hydroxychloroquine Dispensing in the United States, January to May 2020
por: Levin, Zachary, et al.
Publicado: (2021) -
A Brief Review of Silicosis in the United States
por: Thomas, Carson R., et al.
Publicado: (2010)